Age-related eye disorders, such as glaucoma, retinal disorders (age-related macular degeneration, diabetic retinopathy and macular edema), cataracts and macular degeneration are increasing in prevalence. WHO estimates that 285 million people worldwide are visually impaired[1], affected by age-related, genetic, rare and degenerative conditions of the eye.

Modern lifestyle habits, such as the excessive use of visual displays, poor diet and overworking have been associated with other eye disorders, such as dry eye syndrome, allergies, inflammation, conjunctivitis and myopia.

Advancements in technology are having a profound impact on ophthalmological conditions with the emergence of biological medicines and development of the medical devices segment. Innovations in medical devices include surgical, diagnostic and monitoring devices, which offer new and better solutions to patients.

For more than 20 years, Eurotrials has been contributing to these technological advances and following the trends in gene therapy. We are committed to biopharmaceutical, medical device and diagnostic development to optimize the possibility of success.

With more than 20 years of experience in the industry, our multidisciplinary team includes medical, operational, strategy and regulatory specialists, as well as market access experts who plan and implement worldwide studies, guiding you and providing you strategic support in every step of the product lifecycle.

Long-term relationships with medical and scientific leaders and research centers in Europe and Latin America contribute to valued expert input for your projects from project design to patient engagement.

[1] WHO